dc.contributor.author | Ozakman, Selda | |
dc.contributor.author | Goren, M. Zafer | |
dc.contributor.author | Nurten, Asiye | |
dc.contributor.author | Tekin, Nurdan | |
dc.contributor.author | Kalayci, Rivaze | |
dc.contributor.author | Enginar, Nurhan | |
dc.date.accessioned | 2021-12-21T08:47:03Z | |
dc.date.available | 2021-12-21T08:47:03Z | |
dc.date.issued | 2021 | |
dc.identifier.issn | 0028-1298 | |
dc.identifier.issn | 1432-1912 | |
dc.identifier.uri | https://doi.org/10.1007/s00210-020-02001-1 | |
dc.identifier.uri | http://dspace.yeniyuzyil.edu.tr:8080/xmlui/handle/20.500.12629/2157 | |
dc.description.abstract | Protein kinase C inhibitor tamoxifen reduces symptoms of acute mania in bipolar patients and mania-like behaviors in animals. Memory impairment and altered levels of glutamate and glutamate/glutamine ratio have been reported in mania. Tamoxifen suppresses | |
dc.description.sponsorship | Scientific Research Projects Coordination Unit of Istanbul UniversityIstanbul University [31202] | |
dc.language.iso | English | |
dc.publisher | Sprınger | |
dc.title | Effects of tamoxifen and glutamate and glutamine levels in brain regions in repeated sleep deprivation-induced mania model in mice | |
dc.type | Article | |
dc.relation.journal | Naunyn-Schmıedebergs Archıves Of Pharmacology | |
dc.identifier.issue | 4 | |
dc.identifier.startpage | 619 | |
dc.identifier.endpage | 629 | |
dc.identifier.volume | 394 | |
dc.identifier.doi | 10.1007/s00210-020-02001-1 | |
dc.relation.issue | 4 | |
dc.relation.volume | 394 | |